Skip to Main Content

Author Details

Ronald J Messer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
1972
54
30
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36434839Practical Mouse Model to Investigate Therapeutics for Staphylococcusaureus Contaminated Surgical Mesh Implants.J Surg Res2023
36073812CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir.mBio2022
34311582Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.mBio2021
33821272Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques.bioRxiv2021
32576678Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.mBio2020
30670616Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.mBio2019
31792317Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir.Sci Rep2019
30770827A functional subset of CD8[+] T cells during chronic exhaustion is defined by SIRPα expression.Nat Commun2019
29112072An advanced BLT-humanized mouse model for extended HIV-1 cure studies.AIDS2018
29614127Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.PLoS One2018
28765225B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.mBio2017
28330900Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and Testes.J Immunol2017
27099312Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.J Virol2016
26609939No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts.Virology2016
26670699Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.PLoS One2015
26463758Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation.Sci Rep2015
24889233Mice of the resistant H-2(b) haplotype mount broad CD4(+) T cell responses against 9 distinct Friend virus epitopes.Virology2014
25098294Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.J Immunol2014
24769067Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2(-/-)γc(-/-)CD47(-/-) background.J Immunol Methods2014
24872193Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.J Immunol2014
23645880IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infection.J Immunol2013
24021673BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.Blood2013
22821964Negative impact of IFN-γ on early host immune responses to retroviral infection.J Immunol2012
21047954Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell response.J Virol2011
21543647Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways.J Immunol2011
19568424Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells.PLoS One2009
19587016Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads.J Immunol2009
19812147Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.J Virol2009
17959678Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.J Virol2008
18772436Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.Science2008
18390707CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells.J Immunol2008
16517701In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells.J Immunol2006
16051854CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.J Virol2005
15030773Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.Immunity2004
15297622Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.Proc Natl Acad Sci U S A2004
15479805Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection.J Virol2004
11739713Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression.J Virol2002
12133998Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.J Virol2002
11836400Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.J Virol2002
11119573CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.J Virol2001
11459933Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.Proc Natl Acad Sci U S A2001
11134279Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.J Virol2001
10603387Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.Infect Immun2000
10479155The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.J Infect Dis1999
10092812Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.J Immunol1999
9730883Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.J Exp Med1998
7476173Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat-labile enterotoxin.Mol Microbiol1995
8530486Site-directed mutagenic alteration of potential active-site residues of the A subunit of Escherichia coli heat-labile enterotoxin. Evidence for a catalytic role for glutamic acid 112.J Biol Chem1995
7927684Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin.Infect Immun1994
1729180Evidence for proteolytic cleavage of the 120-kilodalton outer membrane protein of rickettsiae: identification of an avirulent mutant deficient in processing.Infect Immun1992
  • 1 - 50 of 54

Recommended Authors

University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2011
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 2
Yale University
Career Start Year 1990
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 10
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 0
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Wistar Institute
Career Start Year 1986
Number of shared co-authors 3
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 4
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 10
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 1
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1977
Number of shared co-authors 1
University of California
Career Start Year 1976
Number of shared co-authors 0
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 0
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Career Start Year 1973
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 1

Collaborators

National Institute of Allergy and Infectious Diseases
Co-authored papers 41
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Co-authored papers 17
National Institute of Allergy and Infectious Diseases
Co-authored papers 5
Co-authored papers 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 3
University of California berkeley
Co-authored papers 3
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Co-authored papers 3
Co-authored papers 2
National Institutes of Allergy and Infectious Disease, National Institutes of Health
Co-authored papers 2
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 2
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
Stanford University
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
University of California, USA Gladstone Institutes san francisco
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
The Rockefeller University
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
University Hospital Essen, Institute for Translational HIV Research
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Gladstone Institutes, University of California san francisco
Co-authored papers 1
Co-authored papers 1